Search
Now showing items 1-1 of 1
Plasma microRNA biomarkers in rectal cancer patients undergoing neoadjuvant therapy
Colorectal cancer (CRC) is the second most common cause of cancer related death worldwide with an expected 1.8 million new cases this year (1). CRC claims approximately 1200 New Zealand lives per year and rectal cancer ...